Last mentioned: 7h ago
Insider Selling
President and another insider report share sales in regulatory filings.
Analyst Downgrade
Wall Street Zen cuts ALHC rating to Hold.
Offering Priced
Secondary offering is priced at $19.46 per share.
Secondary Offering Announced
Company announces intent to sell 13.2 million shares to raise capital.
Q4 Earnings Report
Alignment Healthcare reports a declining net loss for the fourth quarter of 2025.
Alignment Healthcare (NASDAQ: ALHC) has reported significant insider selling, including a 29,113-share disposal by its President, shortly after a major secondary offering. These transactions occur as the company navigates a shift in analyst sentiment and a challenging regulatory environment for Medicare Advantage providers.
Wall Street Zen has lowered its rating on Alignment Healthcare (ALHC) to "Hold," reflecting broader caution within the Medicare Advantage sector. The downgrade comes as specialized insurers face tightening margins and regulatory shifts in the federal reimbursement landscape.